TrialCancer immunity2013

Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanoma.

Jeffrey Weber et al.PubMed ↗Full text ↗

No numbers read from the abstract.